Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$7.42 - $10.54 $14,253 - $20,247
1,921 Added 2.55%
77,293 $611,000
Q1 2024

Apr 16, 2024

BUY
$7.15 - $10.84 $8,765 - $13,289
1,226 Added 1.65%
75,372 $701,000
Q4 2023

Feb 05, 2024

BUY
$6.28 - $8.81 $8,584 - $12,043
1,367 Added 1.88%
74,146 $625,000
Q3 2023

Oct 13, 2023

BUY
$7.55 - $11.25 $549,481 - $818,763
72,779 New
72,779 $564,000

Others Institutions Holding VYGR

About Voyager Therapeutics, Inc.


  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $223M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.